Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

CHINA LONGEVITY GROUP COMPANY LIMITED ʕ਷Ꮂ˂ණྠϞࠢʮ̡

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1863)

UPDATE ON SUSPENSION OF TRADING

This announcement is made by China Longevity Group Company Limited (the "Company", together with its subsidiaries, the "Group") pursuant to Rule 13.24A of the Rules Governing the Listing of Securities on the Stock Exchange of Hong Kong Limited (the "Listing Rules"), and the inside information provisions under Part XIVA of the Securities and Futures Ordinance (Chapter 571, Laws of Hong Kong).

Reference are made to the announcements of the Company dated 13 June 2014, 18 September 2017 and 1 August 2018 (the "Announcements"). Capitalised terms used herein shall have the same meanings as those defined in the Announcements.

PROGRESS OF FULFILLMENT OF THE RESUMPTION CONDITIONS

The Board wishes to update the Shareholders that the Company has made a reply to address the concerns of the Securities and Futures Commission (the "SFC"), and a proposal with a view to resolving the matter and resuming trade in the shares in the Company was made to the SFC on 7 August 2018. The Company is awaiting the SFC's reply.

Save as the aforesaid, the Resumption Conditions have been fulfilled by the Company. Further announcements will be made from time to time to keep the Shareholders updated with the latest development.

Trading of shares of the Company has been suspended since 14 February 2013 and will remain suspended until further notice.

By order of the Board

China Longevity Group Company Limited

Lin Shengxiong

Executive Director

Hong Kong, 26 October 2018

As at the date of this announcement, the Board comprises three executive Directors, namely Mr. Lin Shengxiong, Mr. Huang Wanneng and Mr. Jiang Shisheng, and three independent non-executive Directors are Mr. Lau Chun Pong, Mr. Lu Jiayu and Ms. Jiang Ping.

Attachments

  • Original document
  • Permalink

Disclaimer

China Longevity Group Co. Ltd. published this content on 26 October 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 26 October 2018 12:11:06 UTC